Literature DB >> 22044202

MRI of metastasis-permissive microenvironments.

Marie-France Penet1, Zhihang Chen, Zaver M Bhujwalla.   

Abstract

One of the earliest documented observations of the importance of the microenvironment in metastasis was made by Stephen Paget in 1889. More than a century later, the metastatic cascade remains a major cause of mortality from cancer. Cancer meets the criterion of a successful organization that is able to survive by adapting to changing environments. In fact, the tumor microenvironment and stroma are co-opted and shaped by cancer cells to derive a survival advantage. Cohesive strategies integrating advances in molecular biology and chemistry, with noninvasive multimodality imaging, provide new insights into the role of the tumor microenvironment in promoting metastasis from primary tumors as well as insights into environments that attract and permit cancer cells to establish colonies in distant organs. This article provides an overview of molecular and functional imaging characterization of microenvironments that can promote or permit cancer cells to metastasize and the microenvironmental characteristics of distant metastases.

Entities:  

Mesh:

Year:  2011        PMID: 22044202      PMCID: PMC3235911          DOI: 10.2217/fon.11.114

Source DB:  PubMed          Journal:  Future Oncol        ISSN: 1479-6694            Impact factor:   3.404


  99 in total

1.  In vivo molecular target assessment of matrix metalloproteinase inhibition.

Authors:  C Bremer; C H Tung; R Weissleder
Journal:  Nat Med       Date:  2001-06       Impact factor: 53.440

2.  Imaging prostate cancer invasion with multi-nuclear magnetic resonance methods: the Metabolic Boyden Chamber.

Authors:  U Pilatus; E Ackerstaff; D Artemov; N Mori; R J Gillies; Z M Bhujwalla
Journal:  Neoplasia       Date:  2000 May-Jun       Impact factor: 5.715

3.  A KDR-binding peptide (ST100,059) can block angiogenesis, melanoma tumor growth and metastasis in vitro and in vivo.

Authors:  Luca Rastelli; Maria Luisa Valentino; Melissa Corso Minderman; Judith Landin; Uriel M Malyankar; Mary K Lescoe; Richard Kitson; Kenneth Brunson; Lina Souan; Salvatore Forenza; Ronald H Goldfarb; Shafaat A Rabbani
Journal:  Int J Oncol       Date:  2011-05-11       Impact factor: 5.650

Review 4.  Proteolytic networks in cancer.

Authors:  Steven D Mason; Johanna A Joyce
Journal:  Trends Cell Biol       Date:  2011-01-12       Impact factor: 20.808

5.  Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases.

Authors:  Amita Shukla-Dave; Nancy Y Lee; Jacobus F A Jansen; Howard T Thaler; Hilda E Stambuk; Matthew G Fury; Snehal G Patel; Andre L Moreira; Eric Sherman; Sasan Karimi; Ya Wang; Dennis Kraus; Jatin P Shah; David G Pfister; Jason A Koutcher
Journal:  Int J Radiat Oncol Biol Phys       Date:  2011-05-19       Impact factor: 7.038

6.  MRI and PET/CT of patients with bone metastases from breast carcinoma.

Authors:  J Grankvist; R Fisker; V Iyer; E T Fründ; C Simonsen; T Christensen; L Stenbygaard; M Ewertz; E-M Larsson
Journal:  Eur J Radiol       Date:  2011-01-12       Impact factor: 3.528

7.  Vascular differences detected by MRI for metastatic versus nonmetastatic breast and prostate cancer xenografts.

Authors:  Z M Bhujwalla; D Artemov; K Natarajan; E Ackerstaff; M Solaiyappan
Journal:  Neoplasia       Date:  2001 Mar-Apr       Impact factor: 5.715

Review 8.  Imaging pH and metastasis.

Authors:  Arig Ibrahim Hashim; Xiaomeng Zhang; Jonathan W Wojtkowiak; Gary V Martinez; Robert J Gillies
Journal:  NMR Biomed       Date:  2011-03-08       Impact factor: 4.044

Review 9.  The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture.

Authors:  J M Brown
Journal:  Cancer Res       Date:  1999-12-01       Impact factor: 12.701

10.  Vascular phenotypes in primary non-small cell lung carcinomas and matched brain metastases.

Authors:  A M Jubb; A Cesario; M Ferguson; M T Congedo; K C Gatter; F Lococo; A Mulè; F Pezzella
Journal:  Br J Cancer       Date:  2011-05-03       Impact factor: 7.640

View more
  6 in total

Review 1.  Imaging the Tumor Microenvironment.

Authors:  Valerie S LeBleu
Journal:  Cancer J       Date:  2015 May-Jun       Impact factor: 3.360

Review 2.  Molecular and functional imaging insights into the role of hypoxia in cancer aggression.

Authors:  Samata Kakkad; Balaji Krishnamachary; Desmond Jacob; Jesus Pacheco-Torres; Eibhlin Goggins; Santosh Kumar Bharti; Marie-France Penet; Zaver M Bhujwalla
Journal:  Cancer Metastasis Rev       Date:  2019-06       Impact factor: 9.264

3.  Combining Optical Reporter Proteins with Different Half-lives to Detect Temporal Evolution of Hypoxia and Reoxygenation in Tumors.

Authors:  Pierre Danhier; Balaji Krishnamachary; Santosh Bharti; Samata Kakkad; Yelena Mironchik; Zaver M Bhujwalla
Journal:  Neoplasia       Date:  2015-12       Impact factor: 5.715

4.  Metabolic reprogramming of stromal fibroblasts by melanoma exosome microRNA favours a pre-metastatic microenvironment.

Authors:  Shin La Shu; Yunchen Yang; Cheryl L Allen; Orla Maguire; Hans Minderman; Arindam Sen; Michael J Ciesielski; Katherine A Collins; Peter J Bush; Prashant Singh; Xue Wang; Martin Morgan; Jun Qu; Richard B Bankert; Theresa L Whiteside; Yun Wu; Marc S Ernstoff
Journal:  Sci Rep       Date:  2018-08-27       Impact factor: 4.379

5.  Metabolic consequences of HIF silencing in a triple negative human breast cancer xenograft.

Authors:  Santosh K Bharti; Yelena Mironchik; Flonne Wildes; Marie-France Penet; Eibhlin Goggins; Balaji Krishnamachary; Zaver M Bhujwalla
Journal:  Oncotarget       Date:  2018-02-24

6.  High-resolution Imaging of Myeloperoxidase Activity Sensors in Human Cerebrovascular Disease.

Authors:  Youssef Z Wadghiri; Dung Minh Hoang; Anita Leporati; Matthew J Gounis; Aurora Rodríguez-Rodríguez; Mary L Mazzanti; John P Weaver; Ajay K Wakhloo; Peter Caravan; Alexei A Bogdanov
Journal:  Sci Rep       Date:  2018-05-16       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.